USANA HEALTH SCIENCES INC's ticker is USNA and the CUSIP is 90328M107. A total of 168 filers reported holding USANA HEALTH SCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $830 | -57.2% | 18,360 | -54.1% | 0.00% | -57.1% |
Q1 2024 | $1,937 | -60.1% | 39,974 | -56.0% | 0.01% | -63.2% |
Q4 2023 | $4,860 | -51.6% | 90,792 | -47.0% | 0.02% | -54.8% |
Q3 2023 | $10,037 | -35.4% | 171,428 | -30.5% | 0.04% | -34.4% |
Q2 2023 | $15,544 | -7.4% | 246,753 | -7.6% | 0.06% | -13.5% |
Q1 2023 | $16,778 | -14.3% | 267,057 | -27.5% | 0.07% | -22.9% |
Q4 2022 | $19,570 | -99.9% | 368,315 | -8.2% | 0.10% | -22.0% |
Q3 2022 | $22,469,000 | -30.7% | 401,250 | -10.5% | 0.12% | -25.9% |
Q2 2022 | $32,431,000 | -19.1% | 448,213 | -11.3% | 0.17% | +0.6% |
Q1 2022 | $40,100,000 | -33.4% | 505,053 | -15.2% | 0.16% | -26.7% |
Q4 2021 | $60,216,000 | -2.9% | 595,340 | -11.5% | 0.22% | -4.7% |
Q3 2021 | $61,988,000 | -18.0% | 672,674 | -8.8% | 0.24% | -16.9% |
Q2 2021 | $75,574,000 | +3.9% | 737,814 | -1.0% | 0.28% | +0.4% |
Q1 2021 | $72,762,000 | +24.7% | 745,540 | -1.5% | 0.28% | +25.2% |
Q4 2020 | $58,335,000 | +5.8% | 756,601 | +1.1% | 0.23% | -2.2% |
Q3 2020 | $55,144,000 | -1.6% | 748,721 | -1.9% | 0.23% | -4.1% |
Q2 2020 | $56,048,000 | +25.4% | 763,344 | -1.3% | 0.24% | -5.9% |
Q1 2020 | $44,687,000 | -24.7% | 773,725 | +2.4% | 0.26% | -5.2% |
Q4 2019 | $59,324,000 | +13.4% | 755,240 | -1.3% | 0.27% | +20.5% |
Q3 2019 | $52,320,000 | -19.1% | 765,055 | -6.0% | 0.22% | -27.7% |
Q2 2019 | $64,667,000 | -7.4% | 814,104 | -2.2% | 0.31% | +3.0% |
Q1 2019 | $69,831,000 | -30.8% | 832,600 | -2.9% | 0.30% | -39.8% |
Q4 2018 | $100,968,000 | -4.5% | 857,569 | -2.2% | 0.50% | +14.4% |
Q3 2018 | $105,696,000 | +2.3% | 876,782 | -2.2% | 0.44% | -2.2% |
Q2 2018 | $103,349,000 | +185.1% | 896,350 | +112.4% | 0.45% | +184.7% |
Q1 2018 | $36,246,000 | +270.8% | 421,947 | +219.7% | 0.16% | +273.8% |
Q4 2017 | $9,774,000 | +2425.6% | 131,981 | +1867.2% | 0.04% | +2000.0% |
Q3 2017 | $387,000 | -68.1% | 6,709 | -64.6% | 0.00% | -60.0% |
Q2 2017 | $1,214,000 | -27.3% | 18,939 | -34.7% | 0.01% | -37.5% |
Q1 2017 | $1,671,000 | -68.3% | 29,009 | -66.3% | 0.01% | -69.2% |
Q4 2016 | $5,267,000 | -40.8% | 86,060 | +33.7% | 0.03% | -40.9% |
Q3 2016 | $8,901,000 | -19.0% | 64,349 | -34.7% | 0.04% | -21.4% |
Q2 2016 | $10,988,000 | -56.3% | 98,615 | -52.3% | 0.06% | -55.9% |
Q1 2016 | $25,127,000 | -3.3% | 206,936 | +1.8% | 0.13% | -6.6% |
Q4 2015 | $25,976,000 | +45.5% | 203,322 | +52.6% | 0.14% | +40.2% |
Q3 2015 | $17,854,000 | +1065.4% | 133,200 | +1087.9% | 0.10% | +1285.7% |
Q2 2015 | $1,532,000 | -3.2% | 11,213 | -21.3% | 0.01% | 0.0% |
Q1 2015 | $1,583,000 | +32.8% | 14,244 | +22.6% | 0.01% | +40.0% |
Q4 2014 | $1,192,000 | +1181.7% | 11,616 | +819.7% | 0.01% | – |
Q3 2014 | $93,000 | +675.0% | 1,263 | +725.5% | 0.00% | – |
Q4 2013 | $12,000 | -7.7% | 153 | 0.0% | 0.00% | – |
Q3 2013 | $13,000 | – | 153 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,276 | $3,195,000 | 2.92% |
Capital Impact Advisors, LLC | 21,373 | $1,615,000 | 1.30% |
Matarin Capital Management, LLC | 18,266 | $1,381,000 | 0.85% |
ALGERT GLOBAL LLC | 25,440 | $1,923,000 | 0.51% |
Phocas Financial Corp. | 125,970 | $10,231,000 | 0.48% |
Camarda Financial Advisors, LLC | 6,918 | $523,000 | 0.43% |
Wolf Group Capital Advisors | 6,645 | $502,000 | 0.40% |
Spark Investment Management LLC | 27,100 | $2,048,000 | 0.36% |
CLARK ESTATES INC/NY | 32,059 | $2,423,000 | 0.34% |
JAMES INVESTMENT RESEARCH, INC. | 118,515 | $8,957,000 | 0.28% |